P4567Predictive value of the HAS-BLED, ATRIA, and ORBIT bleeding risk classification in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (NOACs)

Peter Brønnum Nielsen; F Skjoeth; Torben Bjerregaard Larsen; Jette Nordstrøm Kjældgaard; Professor Gregory Lip

doi:10.1093/eurheartj/ehx504.p4567

RDLNetworkEkosistem

Hakkımızda SSS

Giriş yap Başla

Hakkımızda SSS Gizlilik Şartlar İletişim

P4567Predictive value of the HAS-BLED, ATRIA, and ORBIT bleeding risk classification in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (NOACs) — Peter Brønnum Nielsen (2017) | RDL Network

Back

Home
Publications
P4567Predictive value of the HAS-BLED, ATRIA, and ORBIT bleeding risk classification in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (NOACs)

Shared by

Professor Gregory Lip

University of Liverpool

P4567Predictive value of the HAS-BLED, ATRIA, and ORBIT bleeding risk classification in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants (NOACs)

Article 2017 en

Authors

PN
Peter Brønnum Nielsen
FS
F Skjoeth
TL
Torben Bjerregaard Larsen

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

DOI: 10.1093/eurheartj/ehx504.p4567
Year: 2017
Published: —
Language: en

Article Details

Volume: 38
Issue: suppl_1
Link Of The Paper: https://doi.org/10.1093/eurheartj/ehx504.p4567

Timeline

Related publications

Article2017

The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants

Professor Gregory Lip, Flemming Skjøth, Peter Brønnum Nielsen, Jette Nordstrøm Kjældgaard, Torben Bjerregaard Larsen

Article2021

Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal Bleeding

Soonil Kwon, So-Ryoung Lee, Eue-Keun Choi, Euijae Lee, Jin‐Hyung Jung, Kyungdo Han, Myung‐Jin Cha, Seil Oh, Professor Gregory Lip

Letter2023

Antidiabetic drugs and hypoglycaemia risk in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants

Katarzyna Nabrdalik, Hanna Kwiendacz, Professor Gregory Lip

Article2021

Comparison of the HAS-BLED, ORBIT and ATRIA bleeding risk scores in 399,344 patients with atrial fibrillation and cancer

Daniele Pastori, A Marang, Arnaud Bisson, Julien Herbert, Professor Gregory Lip, Laurent Fauchier

Article2021

Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk

Tze‐Fan Chao, Professor Gregory Lip, S.A Chen

Created:

June 19, 2026